Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Metoclopramide
Therapeutic Area : Undisclosed
Study Phase : Phase IV
Sponsor : Nestle Health Sciences SA
Deal Size : Inapplicable
Deal Type : Inapplicable
PEP uP Protocol in Surgical Patients
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
June 02, 2015
Lead Product(s) : Metoclopramide
Therapeutic Area : Undisclosed
Highest Development Status : Phase IV
Sponsor : Nestle Health Sciences SA
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Metoclopramide
Therapeutic Area : Undisclosed
Study Phase : Phase III
Sponsor : Tirat Carmel Mental Health Center
Deal Size : Inapplicable
Deal Type : Inapplicable
Metoclopramide as Treatment of Clozapine-induced Hypersalivation
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
August 21, 2014
Lead Product(s) : Metoclopramide
Therapeutic Area : Undisclosed
Highest Development Status : Phase III
Sponsor : Tirat Carmel Mental Health Center
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Metoclopramide
Therapeutic Area : Gastroenterology
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
January 01, 2014
Lead Product(s) : Metoclopramide
Therapeutic Area : Gastroenterology
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Metoclopramide
Therapeutic Area : Gastroenterology
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
January 01, 2014
Lead Product(s) : Metoclopramide
Therapeutic Area : Gastroenterology
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Metoclopramide
Therapeutic Area : Undisclosed
Study Phase : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Study of Metoclopramide in Small Bowel Capsule Endoscopy
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
June 28, 2012
Lead Product(s) : Metoclopramide
Therapeutic Area : Undisclosed
Highest Development Status : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Metoclopramide
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : IWK Health Centre
Deal Size : Inapplicable
Deal Type : Inapplicable
Prevention of Intraoperative Nausea and Vomiting During Cesarean Section
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
October 07, 2010
Lead Product(s) : Metoclopramide
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : IWK Health Centre
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Metoclopramide
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Ondansetron Versus Metoclopramide in Treatment of Vomiting in Gastroenteritis
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
July 20, 2010
Lead Product(s) : Metoclopramide
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable